LP Rotate Foot System prosthetic device for fitting lower extremity amputations. -Low profile ...
FDA Device Recall #Z-1288-2015 — Class II — March 4, 2015
Recall Summary
| Recall Number | Z-1288-2015 |
| Classification | Class II — Moderate risk |
| Date Initiated | March 4, 2015 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Ossur H / F |
| Location | Reykjavik |
| Product Type | Devices |
| Quantity | 2,194 (1,464 in U.S. and 730 internationally) |
Product Description
LP Rotate Foot System prosthetic device for fitting lower extremity amputations. -Low profile foot module with adjustable shock absorber and rotation with progressive stiffening -Build height: with male pyramid adapter 145 - 153mm (5 11/16 - 6 ) with female pyramid adapter 153 165mm (6 - 6 1/2) -Male pyramid adapter -Female pyramid adapter -Maintenance free, no lubrication required -Maximum weight: 147kg (325lbs) -Available in sizes 22-30
Reason for Recall
The threads of the outer tube of the shock module of LP Rotate are too short, resulting in insecure assembly. Use of the product may cause the patient to fall with continued use, as the shock module can become loose from the foot blade.
Distribution Pattern
Nationwide within the U.S. and internationally to the following foreign countries; Belgium, United Kingdom, Germany, Czech Republic, France, Israel, Poland, Spain, Australia, Japan, Mexico, Bulgaria, Canada, South Korea, Sweden, Finland,
Lot / Code Information
LP Rotate, sizes 25-27 cat.1-6. Product numbers LRP062, LRF062, LRPU62, LRFU62. All from manufacturing lot number HF141022
Other Recalls from Ossur H / F
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0006-2025 | Class II | Miami J Select Collar, Catalog: MJS-101; Miami ... | Aug 20, 2024 |
| Z-1789-2024 | Class II | RKNXC0003, RHEO KNEE XC 3 YR WARRANTY, MD, CE, ... | Mar 25, 2024 |
| Z-1787-2024 | Class II | RKN130002, RHEO KNEE 2 YR WARRANTY, MD, CE, Ext... | Mar 25, 2024 |
| Z-1788-2024 | Class II | RKN130003, RHEO KNEE 3 YR WARRANTY, MD, CE, Ext... | Mar 25, 2024 |
| Z-1790-2024 | Class II | RKNXC0005, RHEO KNEE XC 5 YR WARRANTY, MD, CE, ... | Mar 25, 2024 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.